Holen Sie sich die Stockscreener-App
93.65
0.00%
0.00
Handel nachbörslich:
93.96
0.31
+0.33%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$93.65
Offen:
$93.23
24-Stunden-Volumen:
6.35M
Relative Volume:
0.80
Marktkapitalisierung:
$119.78B
Einnahmen:
$407.94B
Nettoeinkommen (Verlust:
$2.90B
KGV:
41.13
EPS:
2.2771
Netto-Cashflow:
$7.39B
1W Leistung:
-1.41%
1M Leistung:
-12.97%
6M Leistung:
+22.12%
1J Leistung:
+32.24%
1-Tages-Spanne:
$93.21
$94.26
1-Wochen-Bereich:
$93.21
$97.51
52-Wochen-Spanne:
$69.51
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
93.65 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
384.85 | 348.81B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
396.28 | 86.41B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
274.41 | 73.31B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
380.73 | 45.39B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Temporary Mobile CVS Pharmacy Helps Restore Pharmacy Access in Pawling, NY, Following Fire - ACCESS Newswire
Westport Asset Management Inc. Makes New $1.84 Million Investment in CVS Health Corporation $CVS - MarketBeat
United Bank Invests $2.25 Million in CVS Health Corporation $CVS - MarketBeat
Tocqueville Asset Management L.P. Acquires Shares of 301,191 CVS Health Corporation $CVS - MarketBeat
Edmond DE Rothschild Holding S.A. Invests $29.86 Million in CVS Health Corporation $CVS - MarketBeat
17,720 Shares in CVS Health Corporation $CVS Acquired by Foster & Motley Inc. - MarketBeat
CVS Health Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
CVS Health stock holds steady as Argus lifts price target after strong Q2 earnings - Ad-hoc-news.de
ETFs Investing in CVS Health Corporation Stocks - TradingView
Can CVS Health (CVS) Stay Below Fair Value After Strong Results? - Yahoo Finance
How CVS Specialty helps patients overcome barriers to care - CVS Health
CVS Health and Aetna Help Florida City Families Prepare for the School Year at Branches' Back to School Night - ACCESS Newswire
CVS Health (NYSE:CVS) Given New $114.00 Price Target at Argus - MarketBeat
Argus Adjusts Price Target on CVS Health to $114 From $104, Keeps Buy Rating - marketscreener.com
Meeder Advisory Services Inc. Takes Position in CVS Health Corporation $CVS - MarketBeat
Great Lakes Advisors LLC Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Diversify Advisory Services LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
Danske Bank A S Buys Shares of 890,499 CVS Health Corporation $CVS - MarketBeat
Aljian Capital Management LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
Why Is CVS Health (CVS) Adding A Data Leader To Its Board? - Yahoo Finance
CVS Health stock edges higher as strong Q2 earnings and 2026 guidance anchor valuation - AD HOC NEWS
CVS Health: Thank You! Enlightenment Plaza Voltaire Villas Volunteer Day in Los Angeles, California - Yahoo! Finance Canada
Every community deserves a healthier heart - CVS Health
How Should You Approach CVS Health Stock After Q2 Earnings? - The Globe and Mail
Costco Is Getting Into Medicare — Here’s What Its New Health Insurance Plans Could Mean for Seniors - Benzinga
Pzena Investment Management LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
Meeder Asset Management Inc. Invests $5.70 Million in CVS Health Corporation $CVS - MarketBeat
Perigon Wealth Management LLC Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Pallas Capital Advisors LLC Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Principle Wealth Partners LLC Purchases Shares of 20,714 CVS Health Corporation $CVS - MarketBeat
Trust Co. of Vermont Acquires New Stake in CVS Health Corporation $CVS - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS adds JPMorgan data executive to board amid AI push - Yahoo Finance
Focused Alpha LLC Makes New $1.34 Million Investment in CVS Health Corporation $CVS - MarketBeat
Commerzbank Aktiengesellschaft FI Buys Shares of 79,378 CVS Health Corporation $CVS - MarketBeat
Citizens Financial Group Inc. RI Takes Position in CVS Health Corporation $CVS - MarketBeat
Deutsche Bank AG Takes $466.63 Million Position in CVS Health Corporation $CVS - MarketBeat
BlackRock Inc. Buys Shares of 123,223,409 CVS Health Corporation $CVS - MarketBeat
CVS Health (CVS) Announces Board Resignation and Appointment of JPMorgan Executive - GuruFocus
CVS Looks 19.3% Overvalued on GF Value™ as Dividend Sustainabili - GuruFocus
CVS Health Corp (CVS) Shares Fall 3.2% -- GF Value Says Still Ov - GuruFocus
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
CVS makes changes to board of directors - Breakingthenews.net
CVS Health Corp Announces Board Changes - marketscreener.com
JPMorgan’s data chief will join CVS Health’s board this fall - Stock Titan
Why CVS Health (CVS) Stock Is Down Today - Quiver Quantitative
CVS Health Corp Stock (CVS) Moved Down by 3.46% on Aug 17: A Full Analysis - TradingKey
CVS Health: Mental Health Can Shape Heart Health Outcomes - ACCESS Newswire
CVS' Q2 EPS Gains From Improved Health Care Benefits Profitability - Zacks Investment Research
AMG National Trust Bank Makes New $5.84 Million Investment in CVS Health Corporation $CVS - MarketBeat
HBK Sorce Advisory LLC Invests $2.26 Million in CVS Health Corporation $CVS - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):